The drug maker, acquired by Sun Pharma, had a loss of Rs 454 cr in year ago quarter when it took a foreign exchange charge of Rs 360 cr
Its consolidated turnover increased to Rs 247 cr from Rs 175 cr during the same period a year ago
Company had posted a net loss of Rs 80.58 crore during the same period of previous fiscal
Company had posted a net profit of Rs 47.77 crore during the same quarter a year ago
The company had posted a net loss of Rs 454 crore for the same period previous fiscal
Beats analyst estimates, shares down 1%
Consolidated revenue increases 16% to Rs 3,260 cr
Stock falls 4.8% as gross margins come under pressure
Company had reported a net profit of Rs 277 crore in the corresponding period last financial year
Operating margin at 16.3%, EBITDA at Rs 1,242 crore
Company had posted a sales bookings of Rs 632.3 crore in the year-ago period
India, China pull the Swedish telecom equipment maker's revenue up 9% in Jul-Sept
Airline blames ATF price rise, weak rupee for 95% decrease in net profit
The growth of core biopharma business has been muted due to capacity constraints and geo-political challenges in West Asia
Provisions and contingencies jumped 133% year-on-year to Rs 35 cr from Rs 15 cr in the same quarter last year. However, sequentially, it remained unchanged
Stock closes 5% higher following healthy growth
In dollar terms, net profit was up 28.6% at $14.9 million from $11.6 million in the year-ago period
Net sales of the country's third largest software services exporter rose by 7.5% to Rs 11,816 crore in July-September quarter this fiscal